Device Trade Groups Offer Lukewarm Comments On Pre-RFD Draft
BIO and AdvaMed offered multiple concerns about a January US FDA draft guidance formalizing the pre-RFD process, including that the timeline is too long and that the recommended information may not land manufacturers a center designation.
You may also be interested in...
Brad Thompson says that phone calls used in current informal process help sponsors understand Office of Combination Product’s thinking, and that a formalized process envision in the new draft guidance could make this dialogue more difficult.
The US FDA is urging providers to conserve blood test tubes to combat an ongoing shortage.
Women would be better represented in clinical research and device development under a new strategic plan from the US FDA.